Free tool
Oncology stocks
We cover 279 companies grouped under the Oncology theme. The median market value in the group is $128.61M. Across the group, the median move over the past trading day is +1.10%. 47% of the 272 with a 200-day average trade above it. Price change over the past year runs from −76.5% to +196.7% across the middle 80 percent of the group, with a median of −4.9%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
279 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 129.28 EUR | +11.62% | +44.70% | +83.96% |
| MRK | Merck & Co., Inc. | $156.45 | +19.65% | +48.06% | +88.17% |
| AZN.L | AstraZeneca PLC | 12,110.00 GBP | −6.41% | −10.89% | +1.98% |
| AZN | AstraZeneca PLC | $169.66 | +0.01% | −6.39% | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | 144.34 BRL | +0.85% | −12.75% | +1.51% |
| BMY | Bristol-Myers Squibb Company | $67.92 | +8.57% | +28.36% | +49.31% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 7,050.00 JPY | +0.73% | −17.21% | +12.47% |
| RVMD | Revolution Medicines, Inc. | $211.38 | +12.39% | +167.50% | +492.60% |
| ONC | BeOne Medicines AG | $376.37 | +15.49% | +21.01% | +21.95% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,923.00 JPY | +1.16% | −16.08% | −15.95% |
| BNTX | BioNTech SE | $114.05 | +25.21% | +17.95% | +8.55% |
| INCY | Incyte Corporation | $129.72 | +9.13% | +27.90% | +53.04% |
| GMAB | Genmab A/S | $34.36 | +19.31% | +7.98% | +41.34% |
| GE9.DE | GENMAB AS N | 283.30 EUR | +10.97% | +5.71% | −14.41% |
| IPN.PA | Ipsen S.A. | 162.60 EUR | +1.37% | +40.05% | +39.21% |
| EXEL | Exelixis, Inc. | $56.72 | +1.63% | +30.15% | +49.66% |
| SMMT | Summit Therapeutics Inc. | $13.36 | +1.95% | −23.74% | −49.14% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +67.40% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,511.00 JPY | +3.89% | +16.57% | +62.22% |
| CGON | CG Oncology, Inc. | $78.95 | +7.39% | +88.92% | +210.58% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $100.87 | −6.63% | +49.95% | +79.61% |
| COGT | Cogent Biosciences, Inc. | $36.80 | −9.00% | +5.93% | +212.13% |
| ERAS | Erasca, Inc. | $17.76 | −5.88% | +394.71% | +1016.98% |
| 000100.KS | Yuhan Corporation | 86,000.00 KRW | +21.64% | −23.35% | −25.59% |
| RLAY | Relay Therapeutics, Inc. | $20.57 | +10.35% | +151.47% | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $61.01 | +15.69% | +292.60% | +205.89% |
| CELC | Celcuity Inc. | $92.27 | +12.16% | −8.23% | +87.35% |
| TNGX | Tango Therapeutics, Inc. | $24.51 | −8.27% | +174.47% | +264.73% |
| IDYA | IDEAYA Biosciences, Inc. | $42.48 | +15.53% | +25.49% | +71.91% |
| RCUS | Arcus Biosciences, Inc. | $31.57 | +13.40% | +35.55% | +211.03% |
| TLX | Telix Pharmaceuticals Limited | $11.68 | +17.03% | +53.28% | −4.26% |
| TLX.AX | Telix Pharmaceuticals Limited | 16.06 AUD | +10.99% | +41.37% | −12.72% |
| 000105.KS | Yuhan Corporation | 71,600.00 KRW | +17.76% | −29.29% | −31.05% |
| IMNM | Immunome, Inc. | $29.39 | +30.14% | +41.14% | +196.22% |
| ZLAB | Zai Lab Limited | $26.17 | +40.40% | +51.01% | −23.10% |
| SLS | SELLAS Life Sciences Group, Inc. | $14.09 | +29.98% | +223.91% | +637.70% |
| NRIX | Nurix Therapeutics, Inc. | $26.95 | +15.02% | +49.22% | +178.70% |
| NUVB | Nuvation Bio Inc. | $7.10 | +6.61% | −17.25% | +146.53% |
| URGN | UroGen Pharma Ltd. | $46.36 | +11.82% | +104.14% | +150.59% |
| XNCR | Xencor, Inc. Common Stock | $29.30 | +47.53% | +96.38% | +265.79% |
| HCM | HUTCHMED (China) Limited | $12.26 | +10.25% | −10.18% | −23.04% |
| HCM.L | HUTCHMED (China) Limited | 178.00 GBP | +0.85% | −12.75% | −21.24% |
| NANO.PA | Nanobiotix S.A. | 34.14 EUR | +3.96% | +79.68% | +341.09% |
| NBTX | Nanobiotix S.A. | $41.51 | +3.31% | +87.57% | +321.42% |
| NVCR | NovoCure Limited | $17.62 | +3.46% | +34.30% | +50.60% |
| ZYME | Zymeworks Inc. | $27.47 | +19.43% | +3.19% | +88.54% |
| IMCR | Immunocore Holdings plc | $37.40 | +10.75% | +10.72% | +14.76% |
| DMRA | Damora Therapeutics, Inc. | $30.62 | +4.01% | +40.33% | +800.59% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.41% | −12.36% | −44.50% |
| VIR | Vir Biotechnology, Inc. | $10.71 | +21.70% | +80.30% | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $122.72 | +48.84% | +63.54% | +390.10% |
| SNDX | Syndax Pharmaceuticals, Inc. | $19.92 | −2.92% | −6.48% | +27.20% |
| BCAX | Bicara Therapeutics Inc. | $24.58 | −11.61% | +50.06% | +117.14% |
| AAPG | Ascentage Pharma Group Internat | $16.79 | −11.12% | −36.33% | −61.38% |
| AVBP | ArriVent BioPharma, Inc. | $31.35 | +3.95% | +50.72% | +62.02% |
| REPL | Replimune Group, Inc. | $15.80 | +83.08% | +77.53% | +187.80% |
| AKTS | Aktis Oncology, Inc. | $26.69 | +10.24% | +19.15% | +19.15% |
| CGEM | Cullinan Therapeutics, Inc. | $22.95 | +31.67% | +126.78% | +200.39% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.83 | +15.06% | +69.28% | +43.76% |
| DRTS | Alpha Tau Medical Ltd. | $14.70 | +20.39% | +204.35% | +357.94% |
| IMTX | Immatics N.V. | $9.24 | +7.07% | −11.58% | +76.67% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.56 | −35.46% | −4.90% | +217.21% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.56 | +12.69% | +98.91% | +167.16% |
| 2160.T | GNI Group Ltd. | 2,765.00 JPY | +12.58% | +20.74% | +4.54% |
| JANX | Janux Therapeutics, Inc. | $18.68 | +19.97% | +36.85% | −18.82% |
| PHIL.MI | Philogen S.p.A. | 23.35 EUR | −2.71% | +3.88% | +2.12% |
| KURA | Kura Oncology, Inc. | $13.59 | +33.89% | +31.49% | +77.65% |
| CADL | Candel Therapeutics, Inc. | $13.60 | +36.55% | +150.00% | +138.18% |
| GERN | Geron Corporation | $1.55 | +4.73% | +17.42% | +9.15% |
| EUZ.DE | Eckert & Ziegler SE | 13.65 EUR | −0.29% | −9.06% | −23.06% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.91 | −9.16% | −56.84% | +95.17% |
| 4587.T | PeptiDream Inc. | 1,135.00 JPY | +22.00% | −29.98% | −28.26% |
| ANL | Adlai Nortye Ltd. | $13.74 | +13.93% | +895.65% | +737.80% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.75 | +25.03% | +11.76% | +14.75% |
| AURA | Aura Biosciences, Inc. | $7.82 | +9.22% | +47.55% | +19.94% |
| NVCT | Nuvectis Pharma, Inc. | $25.89 | +32.50% | +204.23% | +298.92% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.37 | +7.09% | −23.76% | −3.50% |
| MNPR | Monopar Therapeutics Inc. | $110.82 | +0.44% | +67.88% | +264.30% |
| CTMX | CytomX Therapeutics, Inc. | $3.37 | +3.69% | −20.71% | +68.50% |
| 4588.T | Oncolys BioPharma Inc. | 4,130.00 JPY | +65.80% | +176.44% | +526.71% |
| GUD.TO | Knight Therapeutics Inc. | 9.75 CAD | −0.71% | +64.97% | +49.08% |
| EIKN | Eikon Therapeutics, Inc. | $12.55 | +27.02% | −16.33% | −16.33% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.48 AUD | +16.98% | −33.15% | −27.91% |
| VSTM | Verastem, Inc. | $7.08 | +16.45% | −2.07% | −21.16% |
| SGMT | Sagimet Biosciences Inc. | $10.29 | +38.12% | +71.79% | +45.34% |
| CBIO | Crescent Biopharma, Inc. | $17.00 | +0.41% | +53.43% | +15.65% |
| ARVN | Arvinas, Inc. | $9.60 | +16.79% | −16.30% | +28.34% |
| DCTH | Delcath Systems, Inc. | $16.92 | +41.71% | +70.05% | +55.37% |
| PRLD | Prelude Therapeutics Incorporated | $6.59 | +69.41% | +141.39% | +418.90% |
| CCCC | C4 Therapeutics, Inc. | $4.20 | +16.99% | +117.62% | +66.01% |
| TOI | Starling Oncology Inc | $6.20 | +19.46% | +68.94% | +78.67% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.02 EUR | −0.97% | −91.09% | −91.09% |
| RLMD | Relmada Therapeutics, Inc. | $4.59 | −11.73% | +5.03% | +635.58% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.79 EUR | +5.76% | +374.47% | +1150.00% |
| PBYI | Puma Biotechnology, Inc. | $9.32 | +16.65% | +61.53% | +86.77% |
| CMPX | Compass Therapeutics, Inc. | $2.53 | +21.63% | −51.06% | −16.23% |
| AVCT.L | Avacta Group Plc | 68.80 GBP | +0.44% | +19.65% | +32.31% |
| FENC | Fennec Pharmaceuticals Inc. | $11.71 | +14.69% | +52.47% | +35.38% |
| FHTX | Foghorn Therapeutics Inc. | $6.85 | +31.73% | +31.98% | +30.48% |
| PRTC.L | PureTech Health plc | 118.80 GBP | +0.51% | −4.65% | −11.34% |
| GALT | Galectin Therapeutics Inc. | $3.99 | +18.05% | −1.48% | −0.25% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 15.49 CAD | +5.73% | +48.80% | +27.38% |
| AGEN | Agenus Inc. | $8.36 | +36.38% | +158.82% | +90.43% |
| CATX | Perspective Therapeutics, Inc. | $3.29 | +16.67% | +17.92% | −4.91% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.88 | −13.97% | +183.21% | +113.19% |
| STRO | Sutro Biopharma, Inc. | $21.44 | −10.70% | +95.62% | +155.24% |
| IMRX | Immuneering Corporation | $5.23 | +19.95% | −21.00% | −12.10% |
| BCYC | Bicycle Therapeutics plc | $4.39 | +11.14% | −34.28% | −38.34% |
| RAC.AX | Racura Oncology Ltd | 2.15 AUD | +5.39% | −25.09% | +72.00% |
| WHWK | Whitehawk Therapeutics, Inc. | $5.08 | +37.30% | +108.20% | +198.82% |
| ALXO | ALX Oncology Holdings Inc. | $2.00 | −0.99% | +73.91% | +81.82% |
| CGEN | Compugen Ltd. | $2.87 | +20.59% | +85.16% | +100.70% |
| MGNX | MacroGenics, Inc. Common Stock | $4.17 | +4.25% | +159.01% | +154.27% |
| TNG.PA | Transgene SA | 0.81 EUR | +12.40% | −15.23% | −16.98% |
| GLSI | Greenwich LifeSciences, Inc. | $18.59 | +38.32% | −4.52% | +56.35% |
| PYXS | Pyxis Oncology, Inc. | $3.06 | +5.15% | +166.09% | +120.14% |
| IPHA | Innate Pharma S.A. | $2.27 | +28.10% | +24.73% | +1.34% |
| SPL.AX | Starpharma Holdings Limited | 0.74 AUD | −1.34% | +101.37% | +465.38% |
| ADAG | Adagene Inc. | $3.82 | +8.22% | +107.61% | +62.55% |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +17.37% | +16.21% | +1.84% |
| TARA | Protara Therapeutics, Inc. | $3.97 | −1.73% | −26.21% | +30.16% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.31 | +24.56% | +43.71% | +14.36% |
| NBP | NovaBridge Biosciences | $1.93 | +8.43% | −54.80% | −59.96% |
| CHRS | Coherus Oncology, Inc. | $1.37 | −6.16% | 0.00% | +17.09% |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +4.07% | −17.21% | −24.30% |
| MENS | Jyong Biotech Ltd. | $2.23 | −8.23% | −34.60% | −95.26% |
| CUE | Cue Biopharma, Inc. | $26.76 | −17.84% | +164.69% | +9.05% |
| MOLN | Molecular Partners AG | $4.38 | +9.36% | +3.79% | +3.91% |
| KZIA | Kazia Therapeutics Limited | $13.79 | +12.94% | +175.80% | +83.87% |
| OKUR | OnKure Therapeutics, Inc. | $3.85 | −4.94% | +30.07% | +36.77% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +98.31% |
| INDP | Indaptus Therapeutics, Inc. | $1.10 | −46.32% | −60.04% | −84.51% |
| HPHA.DE | Heidelberg Pharma AG | 2.53 EUR | −1.17% | +1.20% | −44.40% |
| SCLP.L | Scancell Holdings plc | 9.80 GBP | −1.51% | −1.01% | −6.67% |
| ADCT | ADC Therapeutics SA | $1.04 | −8.77% | −70.45% | −66.34% |
| HURA | TuHURA Biosciences, Inc. | $2.04 | −7.69% | +172.00% | −30.85% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | 72.40 PLN | −2.95% | −3.47% | +76.16% |
| BDTX | Black Diamond Therapeutics, Inc. | $2.24 | +29.48% | −10.04% | −21.95% |
| ANIX | Anixa Biosciences, Inc. | $3.66 | +5.78% | +15.82% | +22.00% |
| GNLX | Genelux Corporation | $2.72 | −7.80% | −40.22% | −27.27% |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.71 | +36.92% | −46.96% | −18.72% |
| RVU.WA | Ryvu Therapeutics S.A. | 18.80 PLN | +25.33% | −30.76% | −34.72% |
| 4889.T | Renascience Inc. | 1,378.00 JPY | −7.70% | −3.57% | −37.68% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −80.71% |
| HBP.TO | Helix BioPharma Corp. | 1.99 CAD | +38.19% | −17.08% | +35.37% |
| ONCY | Oncolytics Biotech Inc. | $0.86 | +7.68% | −12.10% | −12.99% |
| 4575.T | CanBas Co., Ltd. | 821.00 JPY | +12.47% | +0.24% | −40.51% |
| ACRV | Acrivon Therapeutics, Inc. | $2.18 | +39.74% | −11.38% | +63.91% |
| 4579.T | RaQualia Pharma Inc. | 571.00 JPY | +26.05% | −41.26% | +4.58% |
| OSE.PA | OSE Immunotherapeutics SA | 3.19 EUR | +0.69% | −39.85% | −47.82% |
| MAIA | MAIA Biotechnology, Inc. | $1.41 | +10.16% | −11.88% | −10.76% |
| CTOR | Citius Oncology, Inc. | $0.81 | +45.70% | −24.99% | −57.14% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.94 | −7.66% | −40.48% | −17.53% |
| POLB.L | Poolbeg Pharma PLC | 8.50 GBP | +38.21% | +117.95% | +161.54% |
| 4888.T | Stella Pharma Corporation | 364.00 JPY | +17.42% | +71.70% | −9.23% |
| CRDF | Cardiff Oncology, Inc. | $1.02 | +21.43% | −61.65% | −53.85% |
| ELTX | Elicio Therapeutics, Inc. | $3.01 | +0.33% | −62.61% | −72.71% |
| APLM | Apollomics, Inc. | $26.50 | +47.22% | +37.31% | +318.64% |
| OSTX | OS Therapies Incorporated | $1.65 | +7.84% | +23.13% | −24.66% |
| PLRX | Pliant Therapeutics, Inc. | $1.14 | +5.56% | −8.80% | −23.49% |
| SAR.L | Sareum Holdings plc | 29.00 GBP | +31.82% | +70.59% | +38.10% |
| XBIT | XBiotech Inc. | $2.30 | +1.77% | −3.36% | −28.13% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +10.59% | +6.10% | −8.10% |
| BOLD | Boundless Bio, Inc. | $2.94 | +18.55% | +140.98% | +160.18% |
| MAAT.PA | MaaT Pharma SA | 3.05 EUR | +8.75% | −45.43% | −39.58% |
| RNXT | RenovoRx, Inc. | $1.42 | +47.15% | +70.06% | +58.13% |
| HRTX | Heron Therapeutics, Inc. | $0.32 | −29.76% | −74.36% | −76.59% |
| XLO | Xilio Therapeutics, Inc. | $9.08 | −0.11% | −3.49% | −7.35% |
| IMM.AX | Immutep Limited | 0.05 AUD | +14.89% | −87.44% | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +13.08% | −13.53% | −13.53% |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% |
| 4572.T | Carna Biosciences, Inc. | 416.00 JPY | +40.54% | +3.48% | +83.26% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −5.00% | −20.83% | −26.92% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| TIL | Instil Bio, Inc. | $7.81 | +9.23% | −30.70% | −69.62% |
| 4597.T | Solasia Pharma K.K. | 29.00 JPY | 0.00% | +3.57% | −23.68% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −15.00% | −18.07% | +58.14% |
| CANTA.ST | Cantargia AB (publ) | 1.90 SEK | +1.71% | −53.86% | −28.93% |
| IBO | Impact BioMedical Inc. | $0.46 | +6.53% | −11.33% | −20.79% |
| SVE.WA | Synthaverse S.A. | 3.04 PLN | +10.55% | −20.73% | −37.70% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +12.77% | +8.16% | −33.75% |
| HOWL | Werewolf Therapeutics, Inc. | $0.89 | +96.47% | +37.98% | −35.04% |
| 4583.T | Chiome Bioscience Inc. | 85.00 JPY | +25.00% | −20.56% | −36.57% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.92 | −72.92% | −73.30% | −69.57% |
| MOC.WA | Molecure S.A. | 6.14 PLN | +2.33% | −6.40% | −21.18% |
| CNTX | Context Therapeutics Inc. | $0.44 | −30.00% | −71.91% | −50.13% |
| 206A.T | PRISM BioLab Co.,LTD | 171.00 JPY | +16.33% | +6.21% | −6.56% |
| SNT.AX | Syntara Limited | 0.03 AUD | +18.18% | −23.53% | −1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | 75.00 JPY | 0.00% | −33.04% | −58.56% |
| ATNM | Actinium Pharmaceuticals, Inc. | $1.08 | +26.46% | −21.17% | −39.66% |
| BCTX | BriaCell Therapeutics Corp. | $3.77 | +6.20% | −47.42% | −49.67% |
| KYNB | Kyntra Bio, Inc. | $8.10 | +14.89% | −11.57% | −23.80% |
| BCT.TO | BriaCell Therapeutics Corp. | 5.14 CAD | +1.98% | −47.66% | −50.62% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −7.35% | −30.00% | −58.28% |
| BYSI | BeyondSpring Inc. | $0.72 | −38.44% | −55.27% | −60.43% |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +36.23% | −53.00% | −58.77% |
| EVAX | Evaxion A/S | $3.35 | +15.92% | −28.87% | +4.49% |
| LTRN | Lantern Pharma Inc. | $2.18 | −21.86% | −29.90% | −52.30% |
| NNG.WA | NanoGroup S.A. | 2.47 PLN | +2.28% | −7.84% | −14.09% |
| NXTC | NextCure, Inc. | $5.91 | +15.43% | −55.50% | +13.33% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.90% | −72.59% | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $2.68 | +13.56% | −71.64% | −76.49% |
| CVM | CEL-SCI Corporation | $1.48 | +25.42% | −71.26% | −85.98% |
| IMU.AX | Imugene Limited | 0.07 AUD | −16.28% | −81.54% | −73.33% |
| MRKR | Marker Therapeutics, Inc. | $1.52 | +24.59% | −1.30% | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +4.96% | −26.80% | −45.96% |
| BFRI | Biofrontera Inc. | $1.51 | +43.81% | +108.28% | +63.77% |
| CCM | Concord Medical Services Holdings Limited | $4.95 | +9.76% | +15.93% | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $0.80 | −21.58% | −63.47% | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $1.33 | +8.13% | +16.67% | +41.34% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −8.00% | −2.13% | −20.00% |
| DEX.ST | DexTech Medical AB | 10.40 SEK | −0.95% | +12.43% | +20.93% |
| RADX | Radiopharm Theranostics Limited | $2.48 | −32.24% | −51.94% | −55.71% |
| TPST | Tempest Therapeutics, Inc. | $1.11 | +18.72% | −62.37% | −89.50% |
| B8FK.DE | Biofrontera AG | 2.52 EUR | −1.95% | −1.18% | −4.55% |
| ABERA.ST | Abera Bioscience AB | 8.14 SEK | −7.29% | +13.06% | −0.12% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +2.76% | −34.65% | −56.43% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −33.33% | −60.00% | −62.96% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.60 | +16.77% | −28.81% | −52.09% |
| MDCX | Medicus Pharma Ltd. | $0.26 | −17.92% | −83.69% | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $4.90 | +7.11% | −51.89% | −37.24% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +20.83% | −11.22% | −31.23% |
| ACTI.ST | Active Biotech AB (publ) | 5.55 SEK | +7.77% | +20.65% | −60.62% |
| AKTX | Akari Therapeutics, Plc | $7.87 | −6.97% | −32.16% | −77.77% |
| ALTME.PA | TME Pharma N.V. | 0.16 EUR | +147.62% | +126.09% | +48.57% |
| PHIO | Phio Pharmaceuticals Corp. | $1.17 | +11.43% | +7.34% | −41.21% |
| GTBP | GT Biopharma, Inc. | $0.30 | −10.27% | −63.32% | −72.50% |
| BLRX | BioLineRx Ltd. | $2.85 | +1.06% | +1.79% | −25.97% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| PDSB | PDS Biotechnology Corporation | $0.22 | −68.04% | −73.41% | −82.96% |
| MBRX | Moleculin Biotech, Inc. | $0.61 | −72.10% | −83.12% | −95.75% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +11.95% | −9.58% | −45.33% |
| APRE | Aprea Therapeutics, Inc. | $0.95 | +51.98% | +11.36% | −40.63% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.35% | −71.71% | −87.99% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +5.05% | −80.92% | −81.94% |
| XBIO | Xenetic Biosciences, Inc. | $3.82 | +52.80% | +77.67% | +33.57% |
| IMNN | Imunon, Inc. | $1.66 | +8.50% | −57.97% | −73.86% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.80 | +14.40% | +9.43% | −11.31% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +1.60% | −77.99% | −89.97% |
| CURX | Curanex Pharmaceuticals Inc | $4.75 | +2495.63% | +1190.76% | +18.16% |
| BOLT | Bolt Biotherapeutics, Inc. | $3.85 | −3.12% | −33.51% | −29.28% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.40% | −24.55% | −74.46% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +1.26% | −17.65% | −17.01% |
| CHOSA.ST | CHOSA Oncology AB | 0.73 SEK | −14.59% | −20.22% | −12.00% |
| ITOC | iTonic Holdings Ltd. | $0.27 | +9.68% | −37.07% | −51.75% |
| LIMN | Liminatus Pharma, Inc. | $4.61 | +4375.73% | +619.19% | +35.59% |
| NCNA | NuCana plc | $1.47 | +16.67% | −59.62% | −56.76% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.18 | −15.83% | −25.60% | −60.36% |
| KAPA | Kairos Pharma, Ltd. | $0.25 | −19.94% | −65.95% | −79.82% |
| NFX.L | Nuformix plc | 0.17 GBP | +3.13% | −44.07% | +106.25% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +25.00% | −47.37% | −54.55% |
| BCAB | BioAtla, Inc. | $3.26 | −4.12% | −87.79% | −81.69% |
| HCWB | HCW Biologics Inc. | $2.60 | −1.89% | +132.14% | −53.15% |
| APVO | Aptevo Therapeutics Inc. | $2.46 | −41.57% | −73.80% | −92.81% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +37.14% |
| OSRH | OSR Health, Inc. | $0.12 | −73.09% | −80.22% | −88.47% |
| CRIS | Curis, Inc. | $1.59 | −66.10% | +62.24% | −3.64% |
| DBP-B.ST | Double Bond Pharmaceutical Int. | 0.15 SEK | +18.62% | +9.33% | +9.33% |
| RDHL | RedHill Biopharma Ltd. | $0.61 | −13.56% | −41.25% | −55.83% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.31 | −25.57% | +11.02% | −16.03% |
| GOVX | GeoVax Labs, Inc. | $0.64 | −15.54% | −87.60% | −96.61% |
| ARTL | Artelo Biosciences, Inc. | $0.72 | −28.99% | −81.18% | −97.47% |
| IVX.AX | Invion Limited | 0.04 AUD | −15.22% | −58.06% | −70.00% |
| VAL.L | ValiRx plc | 0.16 GBP | −3.13% | −57.53% | −73.04% |
| PPBT | Purple Biotech Ltd | $1.65 | +14.58% | −75.00% | −92.53% |
| RNAZ | TransCode Therapeutics, Inc. | $2.53 | −53.58% | −65.81% | −74.16% |
| PPCB | Propanc Biopharma, Inc. | $1.13 | −14.39% | −92.09% | −98.66% |
| SLXN | Silexion Therapeutics Corp | $0.37 | −85.57% | −80.59% | −94.88% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| DCOY | Decoy Therapeutics Inc. | $2.98 | −20.32% | −61.91% | −95.58% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −28.13% | −91.12% | −99.30% |
| PTP.DE | Pentixapharm Holding AG N | 1.88 EUR | −4.57% | +22.08% | +8.55% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.18 | −24.84% | −90.41% | −96.20% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +260.94% |
| MOLN.SW | Molecular Partners AG | 3.53 CHF | +12.06% | +4.13% | +18.66% |
| T9G.DE | Vidac Pharma Holding Plc | 0.43 EUR | −6.97% | −37.21% | −37.21% |
| TRAW | Traws Pharma, Inc. | $0.58 | +11.31% | −56.48% | −58.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.